Merck & Co., Inc. news

   Watch this stock
Showing stories 1 - 10 of about 159   

Articles published

MRK 57.09 -0.99 (-1.70%)
price chart
Pfizer, Merck Focusing On Nanomedicine As Next Disruption In Pharma
Emend (aprepitant), FDA-approved in 2003, is an anti-nausea drug used to prevent chemotherapy induced nausea and vomiting in adult cancer patients and has higher bioavailability.
Merck & Co., Inc. (NYSE:MRK) Reports Strong Sales Of Arthritis And HIV ...
Dallas, Texas 07/31/2014 (ustradevoice) - Merck & Co., Inc. (NYSE:MRK) posted its second quarterly results on Tuesday. The profits were above the street's expectations.
Merck & Co. Stock Rating Reaffirmed by Credit Suisse (MRK)  WKRB News
Double Top Stocks in Focus- Merck & Co., Inc. (NYSE:MRK), U.S. Bancorp ...  eMarketsDaily
Related articles »  
Merck & Co., Inc. (MRK) Tops Q2 EPS by 5c
Merck & Co., Inc. (NYSE: MRK) reported Q2 EPS of $0.85, $0.05 better than the analyst estimate of $0.80. Revenue for the quarter came in at $10.93 billion versus the consensus estimate of $10.6 billion.
Merck & Co., Inc. (MRK) Releases FY14 Earnings Guidance  WKRB News
Merck & Co., Inc. Posts Higher Q2 Profits; Revenue Declines; Beats ...
Related articles »  
Merck quarterly profit beats estimates; shares gain
(Reuters) - Merck & Co Inc reported better-than-expected quarterly results on Tuesday, helped by strong sales of consumer products and medicines for arthritis and HIV, sending its shares up more than 1 percent in morning trading.
Merck's 2nd Quarter profit more than doubles  New Jersey 101.5 FM Radio
Merck second-quarter profit more than doubles, tops forecast  680 News
Related articles »  
Merck & Co., Inc. (MRK) & Pfizer Inc. (PFE): Expectations For The Biopharma ...
Jim Bach: Two American pharmaceutical giants reported earnings this morning, both showing flagging sales - but one ended the day with a gain.
Pfizer Still Looking to Buy; Results Beat Views -- 2nd Update  NASDAQ
Pfizer CEO Still Hunting for Deals and Willing to Go Big  Bloomberg
Related articles »  
Merck lays off 600 more employees at North Wales, Lansdale offices
The Philadelphia Business Journal says the information comes from a Worker Adjustment and Retraining Notification (WARN) notice the pharmaceutical company filed with the Pennsylvania Department of Labor and Industry. Merck officials were not ...
Merck cutting 600 jobs  Albany Business Review (blog)
Related articles »  
ETFs To Watch On Strong Earnings From Pharma Companies
Another chain of forecast-beating earnings from the industry primes like Pfizer (PFE), Merck (MRK), Eli Lilly and Company (LLY) and Bristol-Myers Squibb Company (BMY) is again building up confidence in the sector (read: Healthcare ETFs in Focus on JNJ ...
Related articles »  
Why Merck Is Heading To $65 (MRK)
That and the fact that Merck is getting close to conducting Phase-3 trials for a combination treatment for Hepatitis C puts the company on the offense against Gilead Sciences (NASDAQ:GILD), which is the clear-cut market leader. The recent clinical data ...
Related articles »  
Earnings on Deck: Merck & Co., Inc., Level 3 Communications, Inc., and United ...
This week's slate of quarterly earnings reports picks up the pace tomorrow when global health care concern Merck & Co., Inc. (NYSE:MRK), integrated communications specialist Level 3 Communications, Inc. (NYSE:LVLT), and industrial metals name United ...
Company Update: Merck & Co Inc (NYSE:MRK) � Merck CEO Karl-Ludwig Kley ...
Merck & Co Inc (NYSE:MRK) [at noodls] - News Release Your Contact Gerhard Lerch Tel. 06151 72-6328 Nicole Mommsen Tel. 06151 72 62445 July 28, 2014 Merck CEO Karl-Ludwig Kley and German Federal Economics Minister Sigmar Gabriel ...